Gene · 10521
NIH grants1,197
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 1,197
Download this page as JSON| Grant | Title | DDX17 papers | Newest fiscal year |
|---|---|---|---|
| P01AG060882 | Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease | 1 | 2024 |
| P50CA070907 | Targeting Lung Cancer Vulnerabilities | 1 | 2024 |
| R00NS116679 | Biophysical Determinants of Physiological and Pathological alpha-Synuclein Membrane Interactions | 1 | 2024 |
| R01AI114362 | Transcriptional regulatory mechanisms shaping HIV proviral fate | 1 | 2024 |
| R01AI118426 | Molecular Basis of Human Toxoplasmosis | 1 | 2024 |
| R01AI141448 | Cell Intrinsic Immune Control of KSHV | 1 | 2024 |
| R01AI147640 | Use of Clinical Samples to Identify Influenza Virus Antigenic Variants | 1 | 2024 |
| R01AI150255 | Epigenetic Regulation of HBV cccDNA Transcription | 1 | 2024 |
| R01CA030488 | Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines | 1 | 2024 |
| R01CA186241 | DeSUMOylation regulation of c-Myc | 1 | 2024 |
| R01CA193318 | Damaged RNA as a mediator of alkylation responses | 1 | 2024 |
| R01CA193481 | Sequence-specific Hybridization Capture for Discovery of Proteoform–lncRNA Interactions in Prostate Cancer | 1 | 2024 |
| R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 1 | 2024 |
| R01CA243386 | Targeting FTO to treat acute myeloid leukemia | 1 | 2024 |
| R01CA244993 | Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma | 1 | 2024 |
| R01CA250051 | (PQ#2) Transposable element-mediated gene regulation in KSHV-associated cancer | 1 | 2024 |
| R01DK050189 | Hypoxia, HIF, and Mucosal Inflammation | 1 | 2024 |
| R01DK126662 | The crosstalk of DNA and lysine methyltransferases in ADPKD. | 1 | 2024 |
| R01EY031039 | Nlrp3 inflammasome activation in early diabetic retinopathy | 1 | 2024 |
| R01EY032512 | DICER1 deficiency in aberrant chorioretinal neovascularization | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10521/grants?page=12